Abbas Mohammadi (@drbase_amd) 's Twitter Profile
Abbas Mohammadi

@drbase_amd

Resident Physician @ValleyHealth | Former Scientist @Harvard & @BWH | Ex-CCU Dr @SUMS | ACC Medical Resident❤️‍🩹 | A.I | Health Advocate🩺 | IMG🇺🇸🇮🇷|🏀 Fan

ID: 953899990857994240

linkhttps://linktr.ee/drbase calendar_today18-01-2018 08:00:55

349 Tweet

312 Followers

284 Following

JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Most viewed in the last 7 days from JAMA Cardiology: RCT: Salt substitution reduced the risks of stroke recurrence and death and was a practical therapeutic option for patients with stroke. ja.ma/4hST4zW

Most viewed in the last 7 days from <a href="/JAMACardio/">JAMA Cardiology</a>: 

RCT: Salt substitution reduced the risks of stroke recurrence and death and was a practical therapeutic option for patients with stroke. 

ja.ma/4hST4zW
Gregg W. Stone MD (@greggwstone) 's Twitter Profile Photo

2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Insertion of a microaxial flow pump (Impella) to prevent death in in cardiogenic shock has received a class IIa LOE B-R recommendation. IABP and VA-ECMO are class III for rourine use.

2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Insertion of a
microaxial  flow pump (Impella) to prevent death in in cardiogenic shock has received a class IIa LOE B-R recommendation. IABP and VA-ECMO are class III for rourine use.
American College of Cardiology (@accintouch) 's Twitter Profile Photo

ICYMI: A 🆕 clinical guideline released by ACC/AHA includes new evidence & updated recommendations for managing patients w/ #cvACS. Among the highlights are updated recommendations for pharmacologic care. ➡️ bit.ly/4bohBem #ClinicalGuidelines #JACC JACC Journals

ICYMI: A 🆕 clinical guideline released by ACC/AHA includes new evidence &amp; updated recommendations for managing patients w/ #cvACS. Among the highlights are updated recommendations for pharmacologic care. ➡️ bit.ly/4bohBem

#ClinicalGuidelines #JACC <a href="/JACCJournals/">JACC Journals</a>
Abbas Mohammadi (@drbase_amd) 's Twitter Profile Photo

Four journal acceptances in two weeks, humbled to lead these projects during residency! Grateful for my amazing team. ✔ Canadian Journal of Cardiology ✔ Journal of Cardiovascular Translational Research ✔ Cardiology in Review ✔ Digital Chinese Medicine Journal

Four journal acceptances in two weeks, humbled to lead these projects during residency! Grateful for my amazing team.
✔ Canadian Journal of Cardiology
✔ Journal of Cardiovascular Translational Research
✔ Cardiology in Review
✔ Digital Chinese Medicine Journal
Abbas Mohammadi (@drbase_amd) 's Twitter Profile Photo

🚨 A fascinating report! Primary Atrial Leiomyosarcoma masked by uterine/ovarian history. Collaboration w/ @UHCleveland @CaseMedSchool. 🔗 cjcopen.ca/article/S2589-… #Cardiology #Pathology #MedEd #RareDisease #CardiacSurgery

🚨 A fascinating report! Primary Atrial Leiomyosarcoma masked by uterine/ovarian history. Collaboration w/ @UHCleveland @CaseMedSchool.  

🔗 cjcopen.ca/article/S2589-…

#Cardiology #Pathology #MedEd #RareDisease #CardiacSurgery
Abbas Mohammadi (@drbase_amd) 's Twitter Profile Photo

🚀 Our New publication out! RNA therapies (ASOs, siRNAs) are transforming **CKM Syndrome** care, targeting lipids, BP, obesity, and more. Early intervention + equitable access = future of medicine💡 link.springer.com/article/10.100… #CKM #RNAtherapy #PrecisionMedicine

🚀 Our New publication out!

RNA therapies (ASOs, siRNAs) are transforming **CKM Syndrome** care, targeting lipids, BP, obesity, and more. Early intervention + equitable access = future of medicine💡  
link.springer.com/article/10.100…

#CKM #RNAtherapy #PrecisionMedicine
Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

Thanks so much JACC Journals for showcasing our study led by 🌟Sina Rashedi w support from🗺️experts: OAC monotherapy is✅for most pts w AF + stable CAD. Awaiting data from #AQUATIC. Do the results apply to other indications such as mechanical valves or VTE + stable ASCVD?🤔

Thanks so much <a href="/JACCJournals/">JACC Journals</a> for showcasing our study led by 🌟<a href="/SinaRsh/">Sina Rashedi</a> w support from🗺️experts:

OAC monotherapy is✅for most pts w AF + stable CAD. Awaiting data from #AQUATIC. 

Do the results apply to other indications such as mechanical valves or VTE + stable ASCVD?🤔
Hossein Ardehali (@ardehalihossein) 's Twitter Profile Photo

Another study showing no significant benefit with IV iron in patients with heart failure. I am not sure how many more studies are needed before cardiologists stop using this therapy routinely. jamanetwork.com/journals/jama/…

Abbas Mohammadi (@drbase_amd) 's Twitter Profile Photo

Honored to lead this work! Our latest Cardiology in Review paper highlights cardiovascular risks in transgender individuals & proposes a much-needed risk estimator, something the field lacks. Future studies must validate it to improve care & #HealthEquity #TransgenderHealth

Honored to lead this work! Our latest Cardiology in Review paper highlights cardiovascular risks in transgender individuals &amp; proposes a much-needed risk estimator, something the field lacks. Future studies must validate it to improve care &amp; #HealthEquity #TransgenderHealth
EHJ Editor-in-Chief (@ehj_ed) 's Twitter Profile Photo

Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department. Read more in #EHJ. doi.org/10.1093/eurhea… #AI #EKG European Society of Cardiology Journals European Society of Cardiology

Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department. Read more in #EHJ.
doi.org/10.1093/eurhea…
#AI #EKG <a href="/ESC_Journals/">European Society of Cardiology Journals</a> <a href="/escardio/">European Society of Cardiology</a>
JACC Journals (@jaccjournals) 's Twitter Profile Photo

From the CABANA trial: Patients with #HFpEF benefited even more from #Afib ablation regarding: 🔸Death/CV 🏥 🔸AF recurrence Despite the greater benefit for HFpEF pts, their risk of recurrence remained ⬆️ than in those w/out HFpEF 📎: jacc.org/doi/10.1016/j.… #JACCHF

From the CABANA trial: Patients with #HFpEF benefited even more from #Afib ablation regarding:
🔸Death/CV 🏥 
🔸AF recurrence

Despite the greater benefit for HFpEF pts, their risk of recurrence remained ⬆️ than in those w/out HFpEF

📎: jacc.org/doi/10.1016/j.… #JACCHF
EHJ Editor-in-Chief (@ehj_ed) 's Twitter Profile Photo

New biomarker sub-study to the Phase III trial, FIGARO-DKD, shows that Finerenone modulates a multitude of circulating proteins. academic.oup.com/eurheartj/adva… #finerenone #cardiotwitter, European Society of Cardiology Journals, European Society of Cardiology

New biomarker sub-study to the Phase III trial, FIGARO-DKD, shows that Finerenone modulates a multitude of circulating proteins.
academic.oup.com/eurheartj/adva…
#finerenone #cardiotwitter, <a href="/ESC_Journals/">European Society of Cardiology Journals</a>, <a href="/escardio/">European Society of Cardiology</a>
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Individuals with elevated Lp(a) show significantly higher prevalence of site-specific subclinical #atherosclerosis—especially in severe or multisite cases. Findings indicate that Lp(a) plays a role in the early stage #ASCVD. jacc.org/doi/10.1016/j.… #JACC #ACCIntl

Individuals with elevated Lp(a) show significantly higher prevalence of site-specific subclinical #atherosclerosis—especially in severe or multisite cases. Findings indicate that Lp(a) plays a role in the early stage #ASCVD. jacc.org/doi/10.1016/j.…

#JACC #ACCIntl
Abbas Mohammadi (@drbase_amd) 's Twitter Profile Photo

Proud to lead this study on finerenone, a nonsteroidal MRA with strong trial data in HF. More efficacy, fewer risks, real progress for #heartfailure care. Grateful to my coauthors for the collaboration! #Cardiorenal #Finerenone #ClinicalTrials journals.lww.com/cardiologyinre…

Proud to lead this study on finerenone, a nonsteroidal MRA with strong trial data in HF. More efficacy, fewer risks, real progress for #heartfailure care. Grateful to my coauthors for the collaboration!
#Cardiorenal #Finerenone #ClinicalTrials
journals.lww.com/cardiologyinre…
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Currently in #JACCHF: FUTURE-HF, the first-in-human study of an implantable IVC sensor for remote HF monitoring, was found to be safe & feasible, with improvements in #NTproBNP, NYHA class, #QoL, & reduced #heartfailure events. More: jacc.org/doi/10.1016/j.… Kevin Damman UMCG

Currently in #JACCHF: FUTURE-HF, the first-in-human study of an implantable IVC sensor for remote HF monitoring, was found to be safe &amp; feasible, with improvements in #NTproBNP, NYHA class, #QoL, &amp; reduced #heartfailure events.

More: jacc.org/doi/10.1016/j.… <a href="/kevin_damman/">Kevin Damman</a> <a href="/umcg/">UMCG</a>
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Antiplatelet or anticoagulant? The new ACS guideline decodes the chaos with clarity. A must-read roadmap for frontline care 🧭 jacc.org/doi/10.1016/j.… #JACC #cvACS #ClinicalGuidelines Dr Roxana Mehran David J. Cohen, MD, MSc Behnood Bikdeli Harlan Krumholz

Antiplatelet or anticoagulant? The new ACS guideline decodes the chaos with clarity. A must-read roadmap for frontline care 🧭 jacc.org/doi/10.1016/j.…

#JACC #cvACS #ClinicalGuidelines <a href="/Drroxmehran/">Dr Roxana Mehran</a> <a href="/djc795/">David J. Cohen, MD, MSc</a> <a href="/bbikdeli/">Behnood Bikdeli</a> <a href="/hmkyale/">Harlan Krumholz</a>
Abbas Mohammadi (@drbase_amd) 's Twitter Profile Photo

New Publication! PAD affects 230M+ people globally. Our latest paper explores antithrombotic strategies, dual-pathway inhibition, bleeding risks, and access disparities. 🔗 Read more: journals.lww.com/cardiologyinre… #PAD #Cardiology #VascularMedicine #GlobalHealth

New Publication!
PAD affects 230M+ people globally. Our latest paper explores antithrombotic strategies, dual-pathway inhibition, bleeding risks, and access disparities.
🔗 Read more: journals.lww.com/cardiologyinre…

#PAD #Cardiology #VascularMedicine #GlobalHealth